1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porters Fiver Forces Analysis 40
3 Segmentation of Global Market by Product 45
3.1 Market Overview by Product 45
3.2 Kits & Assays 47
3.3 Analyzers & Instruments 48
3.4 Software & Services 49
4 Segmentation of Global Market by Technology 50
4.1 Market Overview by Technology 50
4.2 Polymerase Chain Reaction (PCR) 52
4.2.1 Real-Time PCR (rt-PCR) 53
4.2.2 Digital PCR (d-PCR) 54
4.3 Isothermal Nucleic Acid Amplification Technology (INAAT) 55
4.4 Genetic Sequencing-based Technology 56
4.5 Microarray-based Technology 57
4.6 Other Technologies 58
5 Segmentation of Global Market by Application 59
5.1 Market Overview by Application 59
5.2 Infectious Disease 61
5.2.1 Respiratory Infections 63
5.2.2 Hospital Acquired Infections 64
5.2.3 Sexually Transmitted Infections 65
5.3 Gastrointestinal Infections 66
5.4 Oncology 67
5.5 Hepatitis 68
5.6 Prenatal/Neonatal Testing 69
5.7 Other Applications 70
6 Segmentation of Global Market by End User 71
6.1 Market Overview by End User 71
6.2 Hospitals 73
6.3 Clinics & Diagnostic Centers 74
6.4 Research and Academic Institutes 75
6.5 Other End Users 76
7 Segmentation of Global Market by Region 78
7.1 Geographic Market Overview 2019-2030 78
7.2 North America Market 2019-2030 by Country 84
7.2.1 Overview of North America Market 84
7.2.2 U.S. 88
7.2.3 Canada 92
7.2.4 Mexico 94
7.3 European Market 2019-2030 by Country 96
7.3.1 Overview of European Market 96
7.3.2 Germany 100
7.3.3 UK 102
7.3.4 France 104
7.3.5 Spain 106
7.3.6 Italy 108
7.3.7 Russia 110
7.3.8 Rest of European Market 112
7.4 Asia-Pacific Market 2019-2030 by Country 114
7.4.1 Overview of Asia-Pacific Market 114
7.4.2 Japan 118
7.4.3 China 121
7.4.4 Australia 124
7.4.5 India 126
7.4.6 South Korea 128
7.4.7 Rest of APAC Region 130
7.5 South America Market 2019-2030 by Country 132
7.5.1 Argentina 135
7.5.2 Brazil 137
7.5.3 Chile 139
7.5.4 Rest of South America Market 141
7.6 MEA Market 2019-2030 by Country 142
7.6.1 UAE 145
7.6.2 Saudi Arabia 147
7.6.3 South Africa 149
7.6.4 Other National Markets 151
8 Competitive Landscape 152
8.1 Overview of Key Vendors 152
8.2 New Product Launch, Partnership, Investment, and M&A 156
8.3 Company Profiles 157
Abacus Diagnostica Oy 157
Abbott Laboratories 159
Alere Inc. 160
Biocartis Group NV 161
Biomerieux SA 162
Bio-Rad Laboratories Inc 163
Danaher Corporation 164
DiaSorin S.p.A 165
DxNA LLC. 166
F. Hoffmann-La Roche Ltd. 167
Hologic, Inc. 168
Luminex Corporation 169
Meridian Bioscience Inc. 170
Mesa Biotech Inc. 171
QIAGEN N.V. 172
QuantuMDx Group Ltd. 173
Quidel Corporation 174
Spartan Biosciences Inc. 175
Thermo Fisher Scientific 176
9 Investing in Global Market: Risk Assessment and Management 177
9.1 Risk Evaluation of Global Market 177
9.2 Critical Success Factors (CSFs) 180
Related Reports and Products 183